Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013818
Filing Date
2020-11-13
Accepted
2020-11-13 16:06:46
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20200930x10q.htm 10-Q 1458481
2 EX-31.1 rsls-20200930ex31112be1b.htm EX-31.1 11678
3 EX-31.2 rsls-20200930ex312b3a4ac.htm EX-31.2 11985
4 EX-32.1 rsls-20200930ex321d8755d.htm EX-32.1 9413
5 EX-32.2 rsls-20200930ex3221f68c3.htm EX-32.2 9287
  Complete submission text file 0001558370-20-013818.txt   4894675

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20200930.xml EX-101.INS 775432
7 EX-101.SCH rsls-20200930.xsd EX-101.SCH 37559
8 EX-101.CAL rsls-20200930_cal.xml EX-101.CAL 56279
9 EX-101.DEF rsls-20200930_def.xml EX-101.DEF 142618
10 EX-101.LAB rsls-20200930_lab.xml EX-101.LAB 320098
11 EX-101.PRE rsls-20200930_pre.xml EX-101.PRE 283384
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

EIN.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 201311507
SIC: 3845 Electromedical & Electrotherapeutic Apparatus